FDA Clearance Tracker · P240036-S004
OmniaSecure MRI SureScan Lead Model 3930M
Last checked: Nov 20, 2026Latest source record: Mar 9, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Mar 9, 2026
Approved
Time to decision
90 days
Received Dec 9, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P240036-S004
- Device name
- OmniaSecure MRI SureScan Lead Model 3930M
- Applicant
- Medtronic, Inc.
- Applicant location
- Mounds View, MN
- Received
- Dec 9, 2025
- Decided
- Mar 9, 2026
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P240036
Device type
- Device type
- Permanent defibrillator electrodes (NVY)
- Device class
- Class III
- Specialty
- CardiologyElectrophysiology
FDA's approval statement
As written in FDA's record.
Approval for updated indications and labeling changes with Left Bundle Branch Area Pacing (LBBAP) application for the OmniaSecure MRI SureScan 3930M lead
Source documents
Other decisions for Medtronic, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K263596 · Decided Oct 29, 2026 · 29 days after receipt
Device type: Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass (DWF) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.